期刊文献+

疏肝健脾饮对糖尿病性胃轻瘫大鼠的干预作用 被引量:1

Intervention of ShuGanJianPi Decoction on diabetic gastroparesis rats:Experimental study
下载PDF
导出
摘要 目的观察疏肝健脾饮对链脲佐菌素致糖尿病性胃轻瘫大鼠的胃肠推进指标及nNOS、5-HT4R、β2-AR等指标的影响并探讨其作用机制。方法以2%链脲佐菌素(STZ)加不规则饮食4周造成糖尿病性胃轻瘫大鼠模型,将30只模型大鼠随机分为模型组和中药组,4周后中药组以相当于成人临床常用剂量的2倍灌胃给药,模型组灌胃等剂量生理盐水,1次/d,给药4周。另取10只正常大鼠作为正常组。实验通过胃肠推进指标和nNOS、5-HT4R、β2-AR免疫组化的结果观察疏肝健脾饮对糖尿病性胃轻瘫大鼠的干预作用。结果疏肝健脾饮不仅降低糖尿病性胃轻瘫大鼠的血糖,还可以明显改善胃肠推进,并改善nNOS、5-HT4R、β2-AR等指标,与模型组比较有显著性差异(P<0.05)。结论疏肝健脾饮能降低糖尿病性胃轻瘫大鼠的血糖,加速胃排空,并改善nNOS、5-HT4R、β2-AR等免疫组化指标。 Objective To observe the effects of ShuGanJianPi Decoction in rat model with diabetic gastroparesis(DGP) on the gastrointestinal propulsion,nNOS,5-HT4R and β2-AR.Method The rats with diabetic gastroparesis induced by injecting 2% STZ and giving irregular diet continuing for 4 weeks,30 diabetic gastroparesis rats were divided into two groups randomly:the treatment group and the control group.Then,the treatment group was given ShuGanJianPi Decoction continuing for 4 weeks at the mount of 2 times of adult common dose.Other groups was given NS of the same mount,once daily,continuing for 4 weeks.Authors chosed 10 rats as the normal group.Then the results of gastrointestinal propulsion,nNOS,5-HT4R and β2-AR were observed.Result The treatment group had better effects than the control group in lowering the blood sugar,improving the level of gastrointestinal propulsion and 5-HT4R,lowering the content of nNOS(P0.01).And there was significant difference between the treatment group and control group(P0.05).Conclusion ShuGanJianPi Decoction has obvious effects in lowering the blood glucose,improving the level of gastrointestinal propulsion and 5-HT4R,and lowering the lever of nNOS.
出处 《实用医药杂志》 2011年第7期630-632,共3页 Practical Journal of Medicine & Pharmacy
关键词 疏肝健脾饮 糖尿病性胃轻瘫 NNOS 5-羟色胺受体(5-HT4R) β2-肾上腺素能受体(β2-AR) ShuGanJianPi Decoction(Decoction for relieving depression of liver-qi and invigorating the spleen) Diabetic gastroparesis nNOS 5-HT4R β2-AR
  • 相关文献

参考文献5

二级参考文献30

  • 1Ozturk Y, Yildizoglu-Ari N, Ozuari A, et al. Decreased beta-adrenergic responses of rat small intestine due to non-insulin-dependent diabetes. Diabetes Res Clin Pract,1990, 9: 123-127.
  • 2Diez-Sampedro A,Milagro FI, Berraonao B, et al. Effects of trecadrine,a beta 3-adrenergic agonist,on intestinal absorption of D-galactose and disaccharidas activies in three phyiopathological models. J Pharm Plarmacol,1997, 49: 873-877.
  • 3Spangeus A, Kand M, El-Salhy M. Gastrointestinal endocrine cells in an animal model for human type 2 diabetes. Dig Dis Sci,1999,44: 979-985.
  • 4Allegra G, Costa R, Scaffidi L, et al. The evaluation of the time of gastric radio-isotopic emptying in subjects with non-insulin dependent diabetes mellitus.Clin Ter,1996,147: 93-80.
  • 5Bouras EP, Camilleri M, Burton DD, et al. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut,1999,44:682-686.
  • 6王龙生 邱曙东 杜俊杰.组织化学[M].西安:陕西出版社,1998.27-28.
  • 7Dubin AE, Huvar R, D'Andrea MR,et al. J Biol Chem,1999;274: 30799 -30810
  • 8Claeysen S , Sebben M , Becamel C , et al . Mol Pharmacol ,1999; 55: 910-920
  • 9Sakurai-Yamashita Y, Yamashita K, Kaibara M, et al. Chin J Physio, 1999 ; 42 : 195 - 198
  • 10Glatzle J, Sternini C, Robin C, et al. Gastroenterology,2002;123:217-226

共引文献24

同被引文献28

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部